Peter Florian

3.3k total citations · 2 hit papers
26 papers, 2.7k citations indexed

About

Peter Florian is a scholar working on Molecular Biology, Neurology and Immunology. According to data from OpenAlex, Peter Florian has authored 26 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Neurology and 6 papers in Immunology. Recurrent topics in Peter Florian's work include Barrier Structure and Function Studies (7 papers), Connexins and lens biology (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Peter Florian is often cited by papers focused on Barrier Structure and Function Studies (7 papers), Connexins and lens biology (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Peter Florian collaborates with scholars based in Germany, United States and France. Peter Florian's co-authors include Michael Fromm, Joachim Mankertz, Christian Bojarski, Bernd Hillenbrand, Frank Heller, A. H. Gitter, Alfred H. Gitter, J Richter, Martin Zeitz and Jörg D. Schulzke and has published in prestigious journals such as Gastroenterology, The Journal of Physiology and PEDIATRICS.

In The Last Decade

Peter Florian

25 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-13 Is the Key Effector Th2 Cytokine in Ulcerative Colitis That Affects Epithelial Tight Junctions, Apoptosis, and Cell Restitution

2005 899 citations Frank Heller, Peter Florian et al. Gastroenterology profile →
Interleukin-13 Is the Key Effector Th2 Cytokine in Ulcerative Colitis That Affects Epithelial Tight Junctions, Apoptosis, and Cell Restitution

2005 855 citations Frank Heller, Peter Florian et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Florian Germany	15	1.1k	790	784	716	499	26	2.7k
J Richter Germany	9	1.1k 1.0×	715 0.9×	723 0.9×	481 0.7×	495 1.0×	12	2.3k
Jörg D. Schulzke Germany	22	1.6k 1.4×	1.6k 2.0×	645 0.8×	475 0.7×	550 1.1×	37	3.6k
Matthias Bruewer Germany	25	1.4k 1.3×	896 1.1×	683 0.9×	475 0.7×	1.1k 2.3×	41	3.6k
Mike G. Laukoetter Germany	20	855 0.8×	337 0.4×	500 0.6×	454 0.6×	825 1.7×	30	2.3k
Ann M. Hopkins Ireland	27	1.5k 1.4×	850 1.1×	342 0.4×	517 0.7×	547 1.1×	49	3.3k
Amanda M. Marchiando United States	11	1.1k 1.0×	878 1.1×	202 0.3×	388 0.5×	310 0.6×	17	2.2k
Ernst–Otto Riecken Germany	30	1.1k 1.0×	404 0.5×	414 0.5×	509 0.7×	660 1.3×	68	3.1k
Agnès Gardet United States	16	1.1k 1.0×	146 0.2×	1.1k 1.4×	945 1.3×	448 0.9×	20	3.0k
Markus Utech Germany	15	805 0.7×	546 0.7×	256 0.3×	191 0.3×	471 0.9×	27	1.8k
Carrie A. Duckworth United Kingdom	25	1.0k 0.9×	155 0.2×	421 0.5×	565 0.8×	645 1.3×	64	2.4k

Countries citing papers authored by Peter Florian

Since Specialization

Citations

This map shows the geographic impact of Peter Florian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Florian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Florian more than expected).

Fields of papers citing papers by Peter Florian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Florian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Florian. The network helps show where Peter Florian may publish in the future.

Co-authorship network of co-authors of Peter Florian

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Florian. A scholar is included among the top collaborators of Peter Florian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Florian. Peter Florian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Leeuw, Thomas, Deimantė Šimaitė, Karen Heyninck, et al.. (2025). Combined TNF-α and OX40L targeting as a new treatment option for hidradenitis suppurativa. Journal of Allergy and Clinical Immunology Global. 4(3). 100483–100483. 3 indexed citations

Suratt, Benjamin T., Tillmann Krahnke, Peter Florian, et al.. (2024). Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study. Respiratory Research. 25(1). 107–107. 12 indexed citations

Schwerk, Nicolaus, Matthias Griese, Peter Florian, et al.. (2023). Severe Neonatal Interstitial Lung Disease Caused by a Rare Surfactant Protein C Mutation. PEDIATRICS. 151(6).

O’Connell, James P., Alison Maloney, Peter Florian, et al.. (2023). Target Occupancy Biomarker Assay Development Using a Conformation-Selective Antibody Against Small-Molecule-Bound TNF. Bioanalysis. 15(6). 343–359. 2 indexed citations

Suratt, Benjamin T., Tillmann Krahnke, Peter Florian, et al.. (2021). Late Breaking Abstract - Immunomodulatory and clinical effects of RIPK1 inhibitor SAR443122 in patients with severe COVID-19. PA2363–PA2363. 2 indexed citations

Klaus, Kristel, et al.. (2020). PH-0361: Reactivation of HCMV during RT of the brain results in critical illness and early mortality. Radiotherapy and Oncology. 152. S193–S194. 1 indexed citations

Pasternack, Ralf, Christiane Pelzer, Michael Sommer, et al.. (2019). Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a). Journal of Thrombosis and Haemostasis. 18(1). 191–200. 28 indexed citations

Bordag, Natalie, Kyriakos D. Economides, Peter Florian, et al.. (2019). LC/MS/MS analyses of open-flow microperfusion samples quantify eicosanoids in a rat model of skin inflammation. Journal of Lipid Research. 60(4). 758–766. 13 indexed citations

Birngruber, Thomas, Barbara Prietl, Manfred Bodenlenz, et al.. (2017). 488 Continuous sampling of immune cells in the skin by dermal open flow microperfusion. Journal of Investigative Dermatology. 137(10). S275–S275. 2 indexed citations

10.

Florian, Peter, et al.. (2017). Anti-GPVI Fab SAR264565 effectively blocks GPVI function in ex vivo human platelets under arterial shear in a perfusion chamber. European Journal of Clinical Pharmacology. 73(8). 949–956. 12 indexed citations

11.

Bodenlenz, Manfred, Barbara Prietl, Peter Florian, et al.. (2017). 502 Characterization of the Psoriasis-like Inflammation in the Imiquimod Rat Model using Dermal Open Flow Microperfusion. Journal of Investigative Dermatology. 137(10). S278–S278. 1 indexed citations

12.

Kozian, Detlef, et al.. (2012). Selective non-lipid modulator of LPA5 activity in human platelets. Bioorganic & Medicinal Chemistry Letters. 22(16). 5239–5243. 32 indexed citations

13.

Günzel, Dorothee, Peter Florian, J Richter, et al.. (2006). Restitution of single-cell defects in the mouse colon epithelium differs from that of cultured cells. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 290(6). R1496–R1507. 30 indexed citations

14.

Heller, Frank, Peter Florian, Christian Bojarski, et al.. (2005). Interleukin-13 Is the Key Effector Th2 Cytokine in Ulcerative Colitis That Affects Epithelial Tight Junctions, Apoptosis, and Cell Restitution. Gastroenterology. 129(2). 550–564. 899 indexed citations breakdown →

15.

Amasheh, Salah, Thomas P. Schmidt, Peter Florian, et al.. (2005). Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells. Cell and Tissue Research. 321(1). 89–96. 163 indexed citations

16.

Florian, Peter, Le Shen, W. Vallen Graham, et al.. (2005). Distinct temporal-spatial roles for rho kinase and myosin light chain kinase in epithelial purse-string wound closure. Gastroenterology. 128(4). 987–1001. 102 indexed citations

17.

Florian, Peter, Salah Amasheh, Ingo Todt, et al.. (2003). Claudins in the tight junctions of stria vascularis marginal cells. Biochemical and Biophysical Research Communications. 304(1). 5–10. 30 indexed citations

18.

Mankertz, Joachim, Bernd Hillenbrand, Shida Tavalali, et al.. (2002). Gene expression of the tight junction protein occludin includes differential splicing and alternative promoter usage. Biochemical and Biophysical Research Communications. 298(5). 657–666. 54 indexed citations

19.

Florian, Peter, Torsten Schöneberg, Jörg–Dieter Schulzke, Michael Fromm, & A. H. Gitter. (2002). Single‐cell epithelial defects close rapidly by an actinomyosin purse string mechanism with functional tight junctions. The Journal of Physiology. 545(2). 485–499. 59 indexed citations

20.

Rokos, K., Peter Florian, Alfred H. Gitter, et al.. (2002). Supernatants of HIV-infected immune cells affect the barrier function of human HT-29/B6 intestinal epithelial cells. AIDS. 16(7). 983–991. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact